Insight into the selective mechanism of phosphoinositide 3‐kinase γ with benzothiazole and thiazolopiperidine γ‐specific inhibitors by in silico approaches
The phosphoinositide 3‐kinase γ (PI3Kγ) has been verified to be a potential drug target for the treatments of various human physical disorders. Although received lots of attention, the development of PI3Kγ‐selective inhibitors is still a challenging subject because of its unique protein structural f...
Saved in:
Published in | Chemical biology & drug design Vol. 93; no. 5; pp. 818 - 831 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
01.05.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 1747-0277 1747-0285 1747-0285 |
DOI | 10.1111/cbdd.13469 |
Cover
Loading…
Abstract | The phosphoinositide 3‐kinase γ (PI3Kγ) has been verified to be a potential drug target for the treatments of various human physical disorders. Although received lots of attention, the development of PI3Kγ‐selective inhibitors is still a challenging subject because of its unique protein structural features. Aiming to uncover the interaction mechanism between the selective inhibitors and PI3Kγ, a series of benzothiazole and thiazolopiperidine PI3Kγ isoform‐selective inhibitors were studied with an integrated in silico strategy by combining molecular docking, molecular dynamic simulations, binding free energy calculations, and decomposition analysis. Firstly, three molecular docking models, including rigid receptor docking, induced fit docking (IFD), and quantum mechanical‐polarized ligand docking, were respectively, built, and the IFD preliminarily predicted the docking poses of all studied inhibitors and roughly analyzed the binding mechanism. Secondly, four binding complexes with representative inhibitors were selected to perform molecular dynamic simulations and free energy calculations. The predicted binding energies were consistent with the experimental bioactivities and different binding patterns between potent and weak inhibitors were uncovered. Finally, through the Molecular Mechanics/Generalized Born Surface Area binding free energy decomposition, residue–inhibitor interactions spectra were obtained and several key residues contributing to favorable binding were highlighted, which provides valuable information for rational PI3Kγ inhibitor design and modification.
A computational strategy, which combines molecular docking, molecular dynamics simulations, free energy calculations, was employed to explore the binding mechanisms of γ‐selective inhibitors to phosphoinositide 3‐kinases γ (PI3Kγ). Several key residues contributing to PI3Kγ‐specific binding were highlighted, which provides valuable information for rational PI3Kγ‐selective inhibitor design. |
---|---|
AbstractList | The phosphoinositide 3‐kinase γ (
PI
3Kγ) has been verified to be a potential drug target for the treatments of various human physical disorders. Although received lots of attention, the development of
PI
3Kγ‐selective inhibitors is still a challenging subject because of its unique protein structural features. Aiming to uncover the interaction mechanism between the selective inhibitors and
PI
3Kγ, a series of benzothiazole and thiazolopiperidine
PI
3Kγ isoform‐selective inhibitors were studied with an integrated in silico strategy by combining molecular docking, molecular dynamic simulations, binding free energy calculations, and decomposition analysis. Firstly, three molecular docking models, including rigid receptor docking, induced fit docking (
IFD
), and quantum mechanical‐polarized ligand docking, were respectively, built, and the
IFD
preliminarily predicted the docking poses of all studied inhibitors and roughly analyzed the binding mechanism. Secondly, four binding complexes with representative inhibitors were selected to perform molecular dynamic simulations and free energy calculations. The predicted binding energies were consistent with the experimental bioactivities and different binding patterns between potent and weak inhibitors were uncovered. Finally, through the Molecular Mechanics/Generalized Born Surface Area binding free energy decomposition, residue–inhibitor interactions spectra were obtained and several key residues contributing to favorable binding were highlighted, which provides valuable information for rational
PI
3Kγ inhibitor design and modification. The phosphoinositide 3‐kinase γ (PI3Kγ) has been verified to be a potential drug target for the treatments of various human physical disorders. Although received lots of attention, the development of PI3Kγ‐selective inhibitors is still a challenging subject because of its unique protein structural features. Aiming to uncover the interaction mechanism between the selective inhibitors and PI3Kγ, a series of benzothiazole and thiazolopiperidine PI3Kγ isoform‐selective inhibitors were studied with an integrated in silico strategy by combining molecular docking, molecular dynamic simulations, binding free energy calculations, and decomposition analysis. Firstly, three molecular docking models, including rigid receptor docking, induced fit docking (IFD), and quantum mechanical‐polarized ligand docking, were respectively, built, and the IFD preliminarily predicted the docking poses of all studied inhibitors and roughly analyzed the binding mechanism. Secondly, four binding complexes with representative inhibitors were selected to perform molecular dynamic simulations and free energy calculations. The predicted binding energies were consistent with the experimental bioactivities and different binding patterns between potent and weak inhibitors were uncovered. Finally, through the Molecular Mechanics/Generalized Born Surface Area binding free energy decomposition, residue–inhibitor interactions spectra were obtained and several key residues contributing to favorable binding were highlighted, which provides valuable information for rational PI3Kγ inhibitor design and modification. A computational strategy, which combines molecular docking, molecular dynamics simulations, free energy calculations, was employed to explore the binding mechanisms of γ‐selective inhibitors to phosphoinositide 3‐kinases γ (PI3Kγ). Several key residues contributing to PI3Kγ‐specific binding were highlighted, which provides valuable information for rational PI3Kγ‐selective inhibitor design. The phosphoinositide 3-kinase γ (PI3Kγ) has been verified to be a potential drug target for the treatments of various human physical disorders. Although received lots of attention, the development of PI3Kγ-selective inhibitors is still a challenging subject because of its unique protein structural features. Aiming to uncover the interaction mechanism between the selective inhibitors and PI3Kγ, a series of benzothiazole and thiazolopiperidine PI3Kγ isoform-selective inhibitors were studied with an integrated in silico strategy by combining molecular docking, molecular dynamic simulations, binding free energy calculations, and decomposition analysis. Firstly, three molecular docking models, including rigid receptor docking, induced fit docking (IFD), and quantum mechanical-polarized ligand docking, were respectively, built, and the IFD preliminarily predicted the docking poses of all studied inhibitors and roughly analyzed the binding mechanism. Secondly, four binding complexes with representative inhibitors were selected to perform molecular dynamic simulations and free energy calculations. The predicted binding energies were consistent with the experimental bioactivities and different binding patterns between potent and weak inhibitors were uncovered. Finally, through the Molecular Mechanics/Generalized Born Surface Area binding free energy decomposition, residue-inhibitor interactions spectra were obtained and several key residues contributing to favorable binding were highlighted, which provides valuable information for rational PI3Kγ inhibitor design and modification. The phosphoinositide 3-kinase γ (PI3Kγ) has been verified to be a potential drug target for the treatments of various human physical disorders. Although received lots of attention, the development of PI3Kγ-selective inhibitors is still a challenging subject because of its unique protein structural features. Aiming to uncover the interaction mechanism between the selective inhibitors and PI3Kγ, a series of benzothiazole and thiazolopiperidine PI3Kγ isoform-selective inhibitors were studied with an integrated in silico strategy by combining molecular docking, molecular dynamic simulations, binding free energy calculations, and decomposition analysis. Firstly, three molecular docking models, including rigid receptor docking, induced fit docking (IFD), and quantum mechanical-polarized ligand docking, were respectively, built, and the IFD preliminarily predicted the docking poses of all studied inhibitors and roughly analyzed the binding mechanism. Secondly, four binding complexes with representative inhibitors were selected to perform molecular dynamic simulations and free energy calculations. The predicted binding energies were consistent with the experimental bioactivities and different binding patterns between potent and weak inhibitors were uncovered. Finally, through the Molecular Mechanics/Generalized Born Surface Area binding free energy decomposition, residue-inhibitor interactions spectra were obtained and several key residues contributing to favorable binding were highlighted, which provides valuable information for rational PI3Kγ inhibitor design and modification.The phosphoinositide 3-kinase γ (PI3Kγ) has been verified to be a potential drug target for the treatments of various human physical disorders. Although received lots of attention, the development of PI3Kγ-selective inhibitors is still a challenging subject because of its unique protein structural features. Aiming to uncover the interaction mechanism between the selective inhibitors and PI3Kγ, a series of benzothiazole and thiazolopiperidine PI3Kγ isoform-selective inhibitors were studied with an integrated in silico strategy by combining molecular docking, molecular dynamic simulations, binding free energy calculations, and decomposition analysis. Firstly, three molecular docking models, including rigid receptor docking, induced fit docking (IFD), and quantum mechanical-polarized ligand docking, were respectively, built, and the IFD preliminarily predicted the docking poses of all studied inhibitors and roughly analyzed the binding mechanism. Secondly, four binding complexes with representative inhibitors were selected to perform molecular dynamic simulations and free energy calculations. The predicted binding energies were consistent with the experimental bioactivities and different binding patterns between potent and weak inhibitors were uncovered. Finally, through the Molecular Mechanics/Generalized Born Surface Area binding free energy decomposition, residue-inhibitor interactions spectra were obtained and several key residues contributing to favorable binding were highlighted, which provides valuable information for rational PI3Kγ inhibitor design and modification. |
Author | Xu, Lei Jin, Jian Li, Kan Zhu, Jingyu |
Author_xml | – sequence: 1 givenname: Jingyu orcidid: 0000-0002-9553-1765 surname: Zhu fullname: Zhu, Jingyu email: jingyuzhu@jiangnan.edu.cn organization: Jiangnan University – sequence: 2 givenname: Kan surname: Li fullname: Li, Kan organization: Jiangnan University – sequence: 3 givenname: Lei orcidid: 0000-0002-4095-6539 surname: Xu fullname: Xu, Lei organization: Jiangsu University of Technology – sequence: 4 givenname: Jian surname: Jin fullname: Jin, Jian email: jianjin@jiangnan.edu.cn organization: Jiangnan University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30582283$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUuO1DAQhi00iHnAhgMgLxFSD7bjOMkSeniMNBIbWEdOuUwKEjvEbkY9K47AFTgD9-AQnIQ03cwCIUoqVZX0_VVS_afsKMSAjD2U4lwu8RQ6585loU1zh53ISlcroery6LavqmN2mtIHIbQuVX2PHReirJWqixP27TIket9nTiFHnnvkCQeETJ-Rjwi9DZRGHj2f-piWpBATZXLIi59fvn6kYBPyH9_5NeWedxhuYu7J3sQBuQ2OH4Y40YQzOQo7eBGmCYE8wXK2p45ynBPvtsvEEw0EkdtpmqOFHtN9dtfbIeGDQz1j716-eLt-vbp68-py_exqBYVqmpVTugJjOmOMVKU3lVYGFRSmAm9BddYKpxoNZS3BiEI5b6DxUlsFoGovizP2eL93Ofxpgym3IyXAYbAB4ya1Shohdd0osaCPDuimG9G100yjnbftn7cuwJM9AHNMaUZ_i0jR7jxrd561vz1bYPEXDJRtphjybGn4t0TuJdc04PY_y9v184uLveYXKVKwJg |
CitedBy_id | crossref_primary_10_1016_j_compbiolchem_2021_107517 crossref_primary_10_1111_cbdd_13991 crossref_primary_10_1039_C9RA02649E crossref_primary_10_1002_adts_202400312 crossref_primary_10_1007_s11224_020_01643_4 crossref_primary_10_1002_adts_202200835 crossref_primary_10_1002_cbdv_201900105 crossref_primary_10_1002_med_21770 crossref_primary_10_1080_13543776_2021_1854729 crossref_primary_10_3389_fmolb_2020_00083 crossref_primary_10_1016_j_compbiomed_2022_105642 crossref_primary_10_1111_cbdd_13838 crossref_primary_10_1007_s11030_024_10918_5 crossref_primary_10_1007_s11030_021_10243_1 crossref_primary_10_1016_j_ejmech_2022_114824 |
Cites_doi | 10.1182/blood-2005-03-0944 10.1002/jcc.10349 10.1021/j100142a004 10.1021/jm051256o 10.1021/jm500362j 10.1002/chin.200318218 10.1021/mp100041b 10.1007/s10822-007-9133-z 10.1021/jp003919d 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A 10.1016/j.bmcl.2006.10.080 10.1038/nrm2882 10.1039/c2mb25114k 10.1021/acs.jctc.5b00864 10.1042/BST0340647 10.1093/carcin/22.11.1831 10.1002/jcc.21366 10.1063/1.464397 10.1021/acs.jmedchem.5b00498 10.1182/blood-2010-03-275305 10.1021/ci200159g 10.1039/C6CP03670H 10.1038/nrd2145 10.1039/C4CP01388C 10.1016/0021-9991(77)90098-5 10.1021/jm0306430 10.1016/j.drudis.2015.03.009 10.1039/c2mb25157d 10.1126/science.296.5573.1655 10.1002/jcc.20290 10.1039/C4CP03179B 10.1021/jp404160y 10.1063/1.445869 10.1093/bioinformatics/btr294 10.1016/S0005-2760(98)00139-8 10.1021/acscentsci.7b00419 10.1002/jcc.20145 10.1038/nri2036 10.1111/cbdd.12907 10.1016/S0022-2836(03)00610-7 10.1038/nri1056 10.1073/pnas.0907304107 10.1016/j.jmb.2007.12.054 10.1002/jcc.20222 10.1006/jmbi.2000.4057 10.1039/c2mb25146a 10.1039/C6CP01555G 10.1038/nchembio.957 10.2174/0929867321666140601204513 10.1039/C7CP07623A 10.1261/rna.065896.118 10.1021/ci300541c 10.1021/jp994072s 10.4049/jimmunol.1103173 10.1039/c2mb25217a 10.1080/07391102.2016.1199328 10.1021/ci400188q |
ContentType | Journal Article |
Copyright | 2018 John Wiley & Sons A/S 2018 John Wiley & Sons A/S. |
Copyright_xml | – notice: 2018 John Wiley & Sons A/S – notice: 2018 John Wiley & Sons A/S. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1111/cbdd.13469 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1747-0285 |
EndPage | 831 |
ExternalDocumentID | 30582283 10_1111_cbdd_13469 CBDD13469 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Fundamental Research Funds for the Central Universities funderid: JUSRP11892 – fundername: National Natural Science Foundation of China funderid: 21807049 |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1OC 29B 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGOF ACMXC ACPOU ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AIACR AITYG AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EAS EBC EBD EBS EJD EMB EMK EMOBN EPT EST ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA HF~ HGLYW HVGLF HZI IHE IX1 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK0 MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N9A NDZJH O66 OIG OVD P2W P4B P4D Q.N Q11 QB0 Q~Q R.K RJQFR ROL RX1 SUPJJ SV3 TEORI TUS UB1 V8K W8V W99 WBKPD WIH WIJ WIK WNSPC WOHZO WOW WQJ WRC WXI WXSBR WYISQ XG1 ~IA ~KM ~WT AAYXX AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM 7X8 AAMMB AEFGJ AGXDD AIDQK AIDYY |
ID | FETCH-LOGICAL-c3299-d247c66b666125f67426e2c367cfac2baa0d294c581c6032df6c9f14a2cc28f13 |
IEDL.DBID | DR2 |
ISSN | 1747-0277 1747-0285 |
IngestDate | Fri Jul 11 14:33:42 EDT 2025 Thu Apr 03 07:11:01 EDT 2025 Thu Apr 24 22:57:09 EDT 2025 Tue Jul 01 04:25:21 EDT 2025 Wed Jan 22 17:00:22 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | selective inhibitor molecular docking PI3Kγ molecular dynamic simulation MM-GBSA |
Language | English |
License | 2018 John Wiley & Sons A/S. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3299-d247c66b666125f67426e2c367cfac2baa0d294c581c6032df6c9f14a2cc28f13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-9553-1765 0000-0002-4095-6539 |
PMID | 30582283 |
PQID | 2160148920 |
PQPubID | 23479 |
PageCount | 14 |
ParticipantIDs | proquest_miscellaneous_2160148920 pubmed_primary_30582283 crossref_primary_10_1111_cbdd_13469 crossref_citationtrail_10_1111_cbdd_13469 wiley_primary_10_1111_cbdd_13469_CBDD13469 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | May 2019 2019-05-00 20190501 |
PublicationDateYYYYMMDD | 2019-05-01 |
PublicationDate_xml | – month: 05 year: 2019 text: May 2019 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Chemical biology & drug design |
PublicationTitleAlternate | Chem Biol Drug Des |
PublicationYear | 2019 |
References | 2010; 11 2017; 3 2011; 117 2006; 34 2010; 107 2017; 89 1977; 23 2005; 26 2014; 21 2001; 105 2017; 35 2000; 96 2013; 53 2005; 106 2013; 117 2014; 16 2003; 3 2007; 7 2011; 27 2007; 21 2010; 7 2007; 17 1998; 1436 2015; 58 2010; 31 2012; 189 2002; 296 2004; 47 2006; 5 2011a; 51 1999; 20 2004 2006; 2 2016; 18 2001; 22 2018; 20 2003; 330 2016; 12 2018; 24 2003; 34 2000; 104 2000; 303 2000; 106 2006; 49 2015; 20 1993; 98 2011b; 32 1993; 97 2011; 51 2003; 24 2008; 376 2012; 8 1998; 79 e_1_2_7_5_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_60_1 e_1_2_7_17_1 e_1_2_7_62_1 e_1_2_7_15_1 e_1_2_7_64_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_11_1 e_1_2_7_45_1 e_1_2_7_47_1 e_1_2_7_49_1 e_1_2_7_28_1 Berman H. M. (e_1_2_7_4_1) 2000; 106 Hou T. (e_1_2_7_26_1) 2011; 32 Hou T. (e_1_2_7_25_1) 2011; 51 e_1_2_7_50_1 e_1_2_7_31_1 e_1_2_7_52_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_54_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_56_1 e_1_2_7_37_1 Sasaki O. (e_1_2_7_41_1) 2000; 96 e_1_2_7_58_1 e_1_2_7_39_1 Xu X. (e_1_2_7_53_1) 2006; 2 e_1_2_7_6_1 e_1_2_7_8_1 e_1_2_7_18_1 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_61_1 e_1_2_7_2_1 e_1_2_7_14_1 e_1_2_7_42_1 e_1_2_7_63_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_10_1 e_1_2_7_46_1 e_1_2_7_48_1 e_1_2_7_27_1 e_1_2_7_29_1 e_1_2_7_51_1 e_1_2_7_30_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_55_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_57_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_59_1 e_1_2_7_38_1 |
References_xml | – volume: 49 start-page: 6177 year: 2006 article-title: Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein−ligand complexes publication-title: Journal of Medicinal Chemistry – volume: 53 start-page: 2376 year: 2013 end-page: 2389 article-title: Insight into crizotinib resistance mechanisms caused by three mutations in ALK tyrosine kinase using free energy calculation approaches publication-title: Journal of Chemical Information and Modeling – volume: 12 start-page: 281 year: 2016 end-page: 296 article-title: OPLS3: A force field providing broad coverage of drug‐like small molecules and proteins publication-title: Journal of Chemical Theory and Computation – volume: 376 start-page: 1201 year: 2008 end-page: 1214 article-title: Characterization of domain‐peptide interaction interface: A case study on the amphiphysin‐1 SH3 domain publication-title: Journal of Molecular Biology – volume: 53 start-page: 210 year: 2013 end-page: 222 article-title: Exploring the molecular mechanism of cross‐resistance to HIV‐1 integrase strand transfer inhibitors by molecular dynamics simulation and residue interaction network analysis publication-title: Journal of Chemical Information and Modeling – volume: 330 start-page: 891 year: 2003 end-page: 913 article-title: Insights into protein‐protein binding by binding free energy calculation and free energy decomposition for the Ras‐Raf and Ras‐RalGDS complexes publication-title: Journal of Molecular Biology – volume: 20 start-page: 14450 year: 2018 end-page: 14460 article-title: Assessing the performance of MM/PBSA and MM/GBSA methods. 7. Entropy effects on the performance of end‐point binding free energy calculation approaches publication-title: Physical Chemistry Chemical Physics – volume: 7 start-page: 191 year: 2007 end-page: 201 article-title: PI3K delta and PI3K gamma: Partners in crime in inflammation in rheumatoid arthritis and beyond? publication-title: Nature Reviews Immunology – volume: 58 start-page: 517 year: 2015 end-page: 521 article-title: Structural basis for isoform selectivity in a class of benzothiazole inhibitors of phosphoinositide 3‐kinase gamma publication-title: Journal of Medicinal Chemistry – volume: 51 start-page: 69 year: 2011a end-page: 82 article-title: Hou T, Wang J, Li Y, Wang W. Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. publication-title: Journal of Computational Chemistry – volume: 5 start-page: 903 year: 2006 end-page: 918 article-title: PI3Kgamma inhibition: Towards an ‘aspirin of the 21st century’? publication-title: Nature Reviews Drug Discovery – volume: 17 start-page: 756 year: 2007 end-page: 760 article-title: Design and synthesis of phenethyl benzo[1,4]oxazine‐3‐ones as potent inhibitors of PI3Kinase gamma publication-title: Bioorganic and Medicinal Chemistry Letters – volume: 26 start-page: 915 year: 2005 article-title: Importance of accurate charges in molecular docking: Quantum mechanical/molecular mechanical (QM/MM) approach publication-title: Journal of Computational Chemistry – volume: 189 start-page: 4612 year: 2012 end-page: 4620 article-title: Blockade of phosphatidylinositol 3‐kinase (PI3K)delta or PI3K gamma reduces IL‐17 and ameliorates imiquimod‐induced psoriasis‐like dermatitis publication-title: Journal of Immunology – volume: 34 start-page: 647 year: 2006 end-page: 662 article-title: Signalling through class I PI3Ks in mammalian cells publication-title: Biochemical Society Transactions – volume: 18 start-page: 12964 year: 2016 article-title: Comprehensive evaluation of ten docking programs on a diverse set of protein‐ligand complexes: The prediction accuracy of sampling power and scoring power publication-title: Physical Chemistry Chemical Physics – volume: 20 start-page: 217 year: 1999 end-page: 230 article-title: Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO) publication-title: Journal of Computational Chemistry – volume: 26 start-page: 1668 year: 2005 end-page: 1688 article-title: The Amber biomolecular simulation programs publication-title: Journal of Computational Chemistry – volume: 21 start-page: 3173 year: 2014 end-page: 3187 article-title: Targeting the phosphatidylinositol 3‐kinase/AKT pathway for the treatment of multiple myeloma publication-title: Current Medicinal Chemistry – volume: 18 start-page: 22129 year: 2016 end-page: 22139 article-title: Assessing the performance of the MM/PBSA and MM/GBSA methods. 6. Capability to predict protein‐protein binding free energies and re‐rank binding poses generated by protein‐protein docking publication-title: Physical Chemistry Chemical Physics – volume: 11 start-page: 329 year: 2010 end-page: 341 article-title: The emerging mechanisms of isoform‐specific PI3K signalling publication-title: Nature Reviews Molecular Cell Biology – volume: 1436 start-page: 127 year: 1998 end-page: 150 article-title: Structure and function of phosphoinositide 3‐kinases publication-title: Biochimica et Biophysica Acta ‐ Molecular and Cell Biology of Lipids – volume: 106 start-page: 1432 year: 2005 end-page: 1440 article-title: Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils publication-title: Blood – volume: 23 start-page: 327 year: 1977 end-page: 341 article-title: Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n ‐alkanes publication-title: Journal of Computational Physics – volume: 35 start-page: 1899 year: 2017 end-page: 1915 article-title: Virtual screening of small molecules databases for discovery of novel PARP‐1 inhibitors: Combination of in silico and in vitro studies publication-title: Journal of Biomolecular Structure and Dynamics – volume: 2 start-page: 95 year: 2006 end-page: 103 article-title: Recent advances in free energy calculations with a combination of molecular mechanics and continuum models publication-title: Current Computer‐Aided Drug Design – volume: 3 start-page: 1208 year: 2017 end-page: 1220 article-title: Combating drug‐resistant mutants of anaplastic lymphoma kinase with potent and selective type‐I (1/2) inhibitors by stabilizing unique DFG‐shifted loop conformation publication-title: ACS Central Science – year: 2004 – volume: 32 start-page: 866 year: 2011b end-page: 877 article-title: Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking publication-title: Journal of Chemical Information and Modeling – volume: 3 start-page: 317 year: 2003 end-page: 330 article-title: PI3K in lymphocyte development, differentiation and activation publication-title: Nature Reviews Immunology – volume: 26 start-page: 114 year: 2005 article-title: Junmei Wang, Romain M. Wolf, James W. Caldwell, Peter A. Kollman, and David A. Case, “Development and testing of a general amber force field” Journal of Computational Chemistry(2004) 25(9) 1157–1174 publication-title: Journal of Computational Chemistry – volume: 105 start-page: 6474 year: 2001 end-page: 6487 article-title: Evaluation and reparametrization of the OPLS‐AA force field for proteins via comparison with accurate quantum chemical calculations on peptides publication-title: Journal of Physical Chemistry B – volume: 117 start-page: 8408 year: 2013 end-page: 8421 article-title: Assessing the performance of MM/PBSA and MM/GBSA methods. 3. The impact of force fields and ligand charge models publication-title: Journal of Physical Chemistry B – volume: 97 start-page: 10269 year: 1993 end-page: 10280 article-title: A well‐behaved electrostatic potential based method using charge restraints for deriving atomic charges ‐ The Resp model publication-title: Journal of Physical Chemistry – volume: 16 start-page: 16719 year: 2014 end-page: 16729 article-title: Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set publication-title: Physical Chemistry Chemical Physics – volume: 104 start-page: 3712 year: 2000 end-page: 3720 article-title: Modification of the generalized born model suitable for macromolecules publication-title: Journal of Physical Chemistry B – volume: 106 start-page: 149 year: 2000 end-page: 158 article-title: The protein data bank publication-title: Genetica – volume: 22 start-page: 1831 year: 2001 end-page: 1835 article-title: Anatomical site‐specific response to DNA damage is related to later tumor development in the rat azoxymethane colon carcinogenesis model publication-title: Carcinogenesis – volume: 98 start-page: 10089 year: 1993 end-page: 10092 article-title: Particle mesh Ewald: An N·log(N) method for Ewald sums in large systems publication-title: Journal of Chemical Physics – volume: 16 start-page: 22035 year: 2014 end-page: 22045 article-title: Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoring publication-title: Physical Chemistry Chemical Physics – volume: 303 start-page: 567 year: 2000 end-page: 582 article-title: Free energy calculations on dimer stability of the HIV protease using molecular dynamics and a continuum solvent model 1 publication-title: Journal of Molecular Biology – volume: 51 start-page: 3235 year: 2011 article-title: Molecular dynamics simulation and free energy calculation studies of the binding mechanism of allosteric inhibitors with p38α MAP kinase publication-title: Journal of Chemical Information and Modeling – volume: 117 start-page: 591 year: 2011 end-page: 594 article-title: CAL‐101, a p110delta selective phosphatidylinositol‐3‐kinase inhibitor for the treatment of B‐cell malignancies, inhibits PI3K signaling and cellular viability publication-title: Blood – volume: 107 start-page: 1321 year: 2010 end-page: 1326 article-title: Detecting and understanding combinatorial mutation patterns responsible for HIV drug resistance publication-title: Proceedings of the National Academy of Sciences of the United States of America – volume: 21 start-page: 681 year: 2007 end-page: 691 article-title: Epik: A software program for pK(a) prediction and protonation state generation for drug‐like molecules publication-title: Journal of Computer‐Aided Molecular Design – volume: 27 start-page: 1814 year: 2011 end-page: 1821 article-title: Prediction of peptides binding to the PKA RIIalpha subunit using a hierarchical strategy publication-title: Bioinformatics – volume: 58 start-page: 5684 year: 2015 end-page: 5688 article-title: Discovery of highly isoform selective thiazolopiperidine inhibitors of phosphoinositide 3‐kinase gamma publication-title: Journal of Medicinal Chemistry – volume: 7 start-page: 894 year: 2010 article-title: In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase publication-title: Molecular Pharmaceutics – volume: 8 start-page: 2135 year: 2012 end-page: 2144 article-title: Understanding the effect of drug‐resistant mutations of HIV‐1 intasome on raltegravir action through molecular modeling study publication-title: Molecular BioSystems – volume: 296 start-page: 1655 year: 2002 end-page: 1657 article-title: The phosphoinositide 3‐kinase pathway publication-title: Science – volume: 8 start-page: 2753 year: 2012 end-page: 2765 article-title: Understanding the structural and energetic basis of inhibitor and substrate bound to the full‐length NS3/4A: Insights from molecular dynamics simulation, binding free energy calculation and network analysis publication-title: Molecular BioSystems – volume: 24 start-page: 1183 year: 2018 end-page: 1194 article-title: Assessing the performance of MM/PBSA and MM/GBSA methods. 8. Predicting binding free energies and poses of protein‐RNA complexes publication-title: RNA (New York, NY) – volume: 47 start-page: 1739 year: 2004 end-page: 1749 article-title: Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy publication-title: Journal of Medicinal Chemistry – volume: 20 start-page: 988 year: 2015 end-page: 994 article-title: Discovery of selective phosphatidylinositol 3‐kinase inhibitors to treat hematological malignancies publication-title: Drug Discovery Today – volume: 34 start-page: 273 year: 2003 end-page: 287 article-title: Mapping the binding site of a large set of quinazoline type EGF‐R inhibitors using molecular field analyses and molecular docking studies publication-title: Cheminform – volume: 89 start-page: 846 year: 2017 end-page: 855 article-title: Theoretical studies on the selective mechanisms of GSK3beta and CDK2 by molecular dynamics simulations and free energy calculations publication-title: Chemical Biology and Drug Design – volume: 31 start-page: 837 year: 2010 end-page: 846 article-title: How to obtain statistically converged MM/GBSA results publication-title: Journal of Computational Chemistry – volume: 24 start-page: 1999 year: 2003 end-page: 2012 article-title: A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations publication-title: Journal of Computational Chemistry – volume: 79 start-page: 926 year: 1998 end-page: 935 article-title: Comparison of simple potential functions for simulating liquid water publication-title: Journal of Chemical Physics – volume: 96 start-page: 704a year: 2000 article-title: Frequent alteration in expression and structure of a candidate tumor suppressor, RIZ, in human leukemia publication-title: Blood – volume: 8 start-page: 2260 year: 2012 article-title: Understanding microscopic binding of macrophage migration inhibitory factor with phenolic hydrazones by molecular docking, molecular dynamics simulations and free energy calculations publication-title: Molecular BioSystems – volume: 8 start-page: 576 year: 2012 end-page: 582 article-title: A selective inhibitor reveals PI3K gamma dependence of T(H)17 cell differentiation publication-title: Nature Chemical Biology – volume: 8 start-page: 3049 year: 2012 end-page: 3060 article-title: Molecular dynamics and free energy studies on Aurora kinase A and its mutant bound with MLN8054: Insight into molecular mechanism of subtype selectivity publication-title: Molecular BioSystems – ident: e_1_2_7_12_1 doi: 10.1182/blood-2005-03-0944 – ident: e_1_2_7_14_1 doi: 10.1002/jcc.10349 – ident: e_1_2_7_2_1 doi: 10.1021/j100142a004 – ident: e_1_2_7_17_1 doi: 10.1021/jm051256o – ident: e_1_2_7_10_1 doi: 10.1021/jm500362j – ident: e_1_2_7_28_1 doi: 10.1002/chin.200318218 – ident: e_1_2_7_33_1 doi: 10.1021/mp100041b – ident: e_1_2_7_42_1 doi: 10.1007/s10822-007-9133-z – ident: e_1_2_7_30_1 doi: 10.1021/jp003919d – ident: e_1_2_7_51_1 doi: 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A – ident: e_1_2_7_31_1 doi: 10.1016/j.bmcl.2006.10.080 – ident: e_1_2_7_47_1 doi: 10.1038/nrm2882 – ident: e_1_2_7_57_1 doi: 10.1039/c2mb25114k – volume: 51 start-page: 69 year: 2011 ident: e_1_2_7_25_1 article-title: Hou T, Wang J, Li Y, Wang W. Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. publication-title: Journal of Computational Chemistry – ident: e_1_2_7_21_1 doi: 10.1021/acs.jctc.5b00864 – ident: e_1_2_7_22_1 doi: 10.1042/BST0340647 – ident: e_1_2_7_23_1 doi: 10.1093/carcin/22.11.1831 – ident: e_1_2_7_19_1 doi: 10.1002/jcc.21366 – ident: e_1_2_7_13_1 doi: 10.1063/1.464397 – ident: e_1_2_7_11_1 doi: 10.1021/acs.jmedchem.5b00498 – ident: e_1_2_7_32_1 doi: 10.1182/blood-2010-03-275305 – ident: e_1_2_7_60_1 doi: 10.1021/ci200159g – ident: e_1_2_7_7_1 doi: 10.1039/C6CP03670H – ident: e_1_2_7_39_1 doi: 10.1038/nrd2145 – ident: e_1_2_7_46_1 doi: 10.1039/C4CP01388C – ident: e_1_2_7_40_1 doi: 10.1016/0021-9991(77)90098-5 – ident: e_1_2_7_16_1 doi: 10.1021/jm0306430 – volume: 96 start-page: 704a year: 2000 ident: e_1_2_7_41_1 article-title: Frequent alteration in expression and structure of a candidate tumor suppressor, RIZ, in human leukemia publication-title: Blood – ident: e_1_2_7_63_1 doi: 10.1016/j.drudis.2015.03.009 – ident: e_1_2_7_58_1 doi: 10.1039/c2mb25157d – ident: e_1_2_7_5_1 doi: 10.1126/science.296.5573.1655 – ident: e_1_2_7_6_1 doi: 10.1002/jcc.20290 – ident: e_1_2_7_45_1 doi: 10.1039/C4CP03179B – ident: e_1_2_7_55_1 doi: 10.1021/jp404160y – ident: e_1_2_7_29_1 doi: 10.1063/1.445869 – ident: e_1_2_7_24_1 doi: 10.1093/bioinformatics/btr294 – ident: e_1_2_7_52_1 doi: 10.1016/S0005-2760(98)00139-8 – ident: e_1_2_7_36_1 doi: 10.1021/acscentsci.7b00419 – ident: e_1_2_7_50_1 doi: 10.1002/jcc.20145 – volume: 106 start-page: 149 year: 2000 ident: e_1_2_7_4_1 article-title: The protein data bank publication-title: Genetica – ident: e_1_2_7_38_1 doi: 10.1038/nri2036 – ident: e_1_2_7_62_1 doi: 10.1111/cbdd.12907 – ident: e_1_2_7_20_1 doi: 10.1016/S0022-2836(03)00610-7 – ident: e_1_2_7_34_1 doi: 10.1038/nri1056 – ident: e_1_2_7_61_1 doi: 10.1073/pnas.0907304107 – volume: 32 start-page: 866 year: 2011 ident: e_1_2_7_26_1 article-title: Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking publication-title: Journal of Chemical Information and Modeling – ident: e_1_2_7_27_1 doi: 10.1016/j.jmb.2007.12.054 – ident: e_1_2_7_9_1 doi: 10.1002/jcc.20222 – ident: e_1_2_7_48_1 doi: 10.1006/jmbi.2000.4057 – ident: e_1_2_7_54_1 doi: 10.1039/c2mb25146a – ident: e_1_2_7_49_1 doi: 10.1039/C6CP01555G – ident: e_1_2_7_3_1 doi: 10.1038/nchembio.957 – ident: e_1_2_7_64_1 doi: 10.2174/0929867321666140601204513 – ident: e_1_2_7_18_1 – ident: e_1_2_7_43_1 doi: 10.1039/C7CP07623A – volume: 2 start-page: 95 year: 2006 ident: e_1_2_7_53_1 article-title: Recent advances in free energy calculations with a combination of molecular mechanics and continuum models publication-title: Current Computer‐Aided Drug Design – ident: e_1_2_7_8_1 doi: 10.1261/rna.065896.118 – ident: e_1_2_7_56_1 doi: 10.1021/ci300541c – ident: e_1_2_7_35_1 doi: 10.1021/jp994072s – ident: e_1_2_7_37_1 doi: 10.4049/jimmunol.1103173 – ident: e_1_2_7_59_1 doi: 10.1039/c2mb25217a – ident: e_1_2_7_15_1 doi: 10.1080/07391102.2016.1199328 – ident: e_1_2_7_44_1 doi: 10.1021/ci400188q |
SSID | ssj0044528 |
Score | 2.2985778 |
Snippet | The phosphoinositide 3‐kinase γ (PI3Kγ) has been verified to be a potential drug target for the treatments of various human physical disorders. Although... The phosphoinositide 3‐kinase γ ( PI 3Kγ) has been verified to be a potential drug target for the treatments of various human physical disorders. Although... The phosphoinositide 3-kinase γ (PI3Kγ) has been verified to be a potential drug target for the treatments of various human physical disorders. Although... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 818 |
SubjectTerms | Benzothiazoles - chemistry Benzothiazoles - metabolism Binding Sites Catalytic Domain Class Ib Phosphatidylinositol 3-Kinase - chemistry Class Ib Phosphatidylinositol 3-Kinase - metabolism Enzyme Inhibitors - chemistry Enzyme Inhibitors - metabolism Humans Ligands MM‐GBSA molecular docking Molecular Docking Simulation molecular dynamic simulation Molecular Dynamics Simulation PI3Kγ Piperidines - chemistry Piperidines - metabolism selective inhibitor Thermodynamics |
Title | Insight into the selective mechanism of phosphoinositide 3‐kinase γ with benzothiazole and thiazolopiperidine γ‐specific inhibitors by in silico approaches |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcbdd.13469 https://www.ncbi.nlm.nih.gov/pubmed/30582283 https://www.proquest.com/docview/2160148920 |
Volume | 93 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELaqXtoLUMrP8idX9AJSVomTOInUC2ypWiQ4ICr1giL_qla3zorsHtgTj8Ar9Bn6Hn0InoQZJ9lSQEhwiBRL4_zYY8839vgbQnbBBjClYxHpNOdRxmwcVbbMoxxsW5xZmTCJSwPv3vPD4-ztSX6yRvaGszAdP8RqwQ1HRpivcYAL2f40yJXUepyk4N7BBIzBWoiIPqy4o7IsD4lVAXEXYaOy5ybFMJ7rqjet0W8Q8yZiDSbn4Db5NHxsF2lyNl7M5Vgtf-Fx_N-_uUNu9ViUvuqUZ4usGX-XbEyGFHDb5OLIt-i8U-fnDQWoSNuQNgdmSHpu8Mywa89pY-nstGnhcj6EgGlD0-9fv505DyaSXl1SXOyl0vglqIUTy2ZqqPCa9oVm5pBuGYwoCkNFPP2JEUzw2lMnHeYDovILlGjrpqC5dCBCN-09cnzw5uPkMOpzOkQqBcsXaZYVinMJXhNAK8vBM-eGqZQXygrFpBCxZlWm8jJRPE6ZtlxVNskEU4qVNknvk3XfePOQ0MLm0uYirkpuoN0AeNgS3K-k5LjbKIoReTH0ba16wnPMuzGtB8cHG70OjT4iz1eys47m449SO4OK1NATuLUivGkWbc0SjkuzFYtH5EGnO6vnwIxaIsnQiLwMGvCXF9ST1_v74e7Rvwg_JpuA46ouDvMJWZ9_XpingJXm8lkYEz8AN1cU4A |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELagHMqF_58tf0ZwASmrxEmc5Ahbqi20PaBW6i3yr2p166zI7qF74hF4BZ6B9-AheBJmnGShgJDgECmW7Fixx55vxuNvCHkOOoApHYtIpzmPMmbjqLJlHuWg2-LMyoRJdA3sH_DpUfb2OD_uY3PwLkzHD7F2uOHKCPs1LnB0SP-0ypXUepykYN9dJlcwpXewqN6v2aOyLA-pVQFzF-GosmcnxUCeH20v6qPfQOZFzBqUzs71LrNqG7gKMdbkdLxcyLFa_cLk-N__c4Nc6-EofdXJz01yyfhbZHMyZIG7TT7v-hbtd-r8oqGAFmkbMufAJknPDF4bdu0ZbSydnzQtPM6HKDBtaPrt46dT50FL0q9fKPp7qTR-BZLhxKqZGSq8pn2hmTtkXAY9ipWhIV4AxSAm6PbESYcpgag8hxJt3QyElw5c6Ka9Q4523hxOplGf1iFSKSi_SLOsUJxLMJwAXVkOxjk3TKW8UFYoJoWINasylZeJ4nHKtOWqskkmmFKstEl6l2z4xpv7hBY2lzYXcVVyA-MG2MOWYIElJccDR1GMyIthcmvVc55j6o1ZPdg-OOh1GPQRebauO--YPv5Y6-kgIzXMBJ6uCG-aZVuzhKN3tmLxiNzrhGf9HdhUS-QZGpGXQQT-0kE9eb29Hd62_qXyE7I5Pdzfq_d2D949IFcB1lVdWOZDsrH4sDSPADot5OOwQL4DW9wY-w |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtQwEB2VIgEvLbfCUi5G8AJSVomTOInEC-yyarlUCFGpLyjyVY26dVZk96H7xCfwC3xD_6MfwZcwdpKFAkKCh0ixNM7FHnvO2OMzAI_RBlCpQh6oOGVBQk0YFCZPgxRtW5gYEVHhlgbe7rGd_eTVQXqwBs_6szAtP8Rqwc2NDD9fuwE-U-anQS6FUsMoRvfuAlxMWJg7nR6_X5FHJUnqM6si5M78TmVHTurieH7UPW-OfsOY5yGrtzmTTfjYf20banI0XMzFUC5_IXL839-5ChsdGCXPW-25BmvaXofLoz4H3A34umsb572Tys5rgliRND5vDk6R5Fi7Q8NVc0xqQ2aHdYNXZX0MmNIk_vb5y1Fl0UaSs1PiVnuJ0HaJelHxZT3VhFtFukI9qxzfMlpRJ4wV3fFPF8KErz2sROUSAhFxgiXSVFNUXdIzoevmJuxPXn4Y7QRdUodAxmj6AkWTTDIm0G1CbGUYuuZMUxmzTBouqeA8VLRIZJpHkoUxVYbJwkQJp1LS3ETxFqzb2urbQDKTCpPysMiZxnZD5GFy9L-inLntRp4N4Enft6XsGM9d4o1p2Xs-rtFL3-gDeLSSnbU8H3-UetirSIk94fZWuNX1oilpxNzabEHDAdxqdWf1HJxSc8cyNICnXgP-8oJy9GI89nd3_kX4AVx6N56Ub3b3Xm_DFcR0RRuTeRfW558W-h7iprm474fHdy4yF7M |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Insight+into+the+selective+mechanism+of+phosphoinositide+3-kinase+%CE%B3+with+benzothiazole+and+thiazolopiperidine+%CE%B3-specific+inhibitors+by+in+silico+approaches&rft.jtitle=Chemical+biology+%26+drug+design&rft.au=Zhu%2C+Jingyu&rft.au=Li%2C+Kan&rft.au=Xu%2C+Lei&rft.au=Jin%2C+Jian&rft.date=2019-05-01&rft.issn=1747-0285&rft.eissn=1747-0285&rft.volume=93&rft.issue=5&rft.spage=818&rft_id=info:doi/10.1111%2Fcbdd.13469&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1747-0277&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1747-0277&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1747-0277&client=summon |